Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
Jan 30, 2018
| Rachel Schwartz
AAM Member Fresenius Kabi Testifies Before Congress on Drug Compounding
Amicus Brief
Jan 26, 2018
| Erica Klinger
PFIZER, INC. v. JOHNSON & JOHNSON and JANSSEN BIOTECH, INC.
Video
Jan 26, 2018
| Erica Klinger
Save the Date for Access! 2018 - AAM Annual Meeting
Video
Jan 26, 2018
| Erica Klinger
Access! 2018 - Who You Need to Know
Video
Jan 26, 2018
| Erica Klinger
Access! 2018 - What You Need to Know
Video
Jan 26, 2018
| Erica Klinger
Access! 2018 - Who You Need to Hear
Video
Jan 26, 2018
| Erica Klinger
Access! 2018 - Keynote Speaker Rob O'Neill
Blog
Jan 25, 2018
| Erik Komendant
Anti-Competitive Evergreening Delays Patient Access to More Affordable Generics and Biosimilars
Fact Sheet
Jan 22, 2018
| Erica Klinger
Oppose Virginia Senate Bill 223
Blog
Jan 9, 2018
| Erica Klinger
Access! 2017 Recap: Ramping Up for AAM’s 2018 Annual Meeting
Fact Sheet
Jan 8, 2018
| Erica Klinger
Oppose Washington Senate Bill 5995
Report
Jan 4, 2018
| Erica Klinger
7 Policy Solutions
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action